Skip to main content
GORE® VIATORR® TIPS Endoprosthesis with Controlled Expansion

Consider TIPS in Treating Portal Hypertension

Time to Rethink TIPS

Advanced by compelling evidence, earlier transjugular intrahepatic portosystemic shunt (TIPS) is helping physicians increase survival in high-risk liver disease patients.

Higher survival with TIPS comparison

READ ABOUT 20 YEARS OF TIPS

READ ABOUT EARLIER TIPS FOR ASCITES AND VARICEAL BLEEDING

INDICATIONS FOR USE IN THE U.S.: The GORE® VIATORR® TIPS Endoprosthesis is indicated for use in the de novo and revision treatment of portal hypertension and its complications such as variceal bleeding, gastropathy, refractory ascites, and/or hepatic hydrothorax.

Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. RXOnly

eIFU Symbol

Footnotes & References

* Early TIPS (n = 29) compared to large-volume paracenteses and albumin infusion (LVP+A) (n = 33).

† Early TIPS (n = 66) compared to pharmacotherapy+endoscopic band ligation (EBL) (n = 605). Child-Pugh C patients with scores < 14.

  1. Bureau C, Thabut D, Oberti D, et al.  Transjugular intrahepatic portosystemic shunts with covered stents increase transplant-free survival of patients with cirrhosis and recurrent ascites.  Gastroenterology 2017;152(1):157-163.  http://www.sciencedirect.com/science/article/pii/S0016508516351101
  2.  Hernández-Gea V, Procopet B, Giráldez Á, et al; International Variceal Bleeding Observational Study Group and Baveno Cooperation.  Preemptive-TIPS improves outcome in high-risk variceal bleeding: an observational study.  Hepatology 2019;69(1):282-293.  https://aasldpubs.onlinelibrary.wiley.com/doi/full/10.1002/hep.30182

22705852-EN